Moreover, NCOA2 gene fusions have been identified in multiple cancer types, including spindle cell sarcomas [32], leukemia [33], rhabdomyosarcoma [34], and uterine sarcoma [35]. This evidence concerns the gene NCOA2 and spindle cell sarcoma.